flubhpve6e7
Vaccineexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 31, 2020 (NCT04490512)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human papillomavirusUnclear
Human papillomavirus unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06589609 | Phase 1 | Aug 23, 2024 | BlueSky Immunotherapies GmbH |
| NCT05829629 | Phase 1 | Sep 12, 2023 | BlueSky Immunotherapies GmbH |
| NCT04490512 | Phase 1 | Aug 31, 2020 | BlueSky Immunotherapies GmbH |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BlueSky Immunotherapies GmbH | For profit | 3 | 3 | 1 | 2020 |
1 organizations
Page 1 / 1